VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions
VC firm Sofinnova banks $1B from Apollo to invest in [...]
AbbVie coughs up nearly $50M for Cugene’s autoimmune med in a bid to shore up life post-Humira
AbbVie coughs up nearly $50M for Cugene’s autoimmune med in [...]
Update: Checkmate details bleak future if $250M Regeneron merger does not close
Update: Checkmate details bleak future if $250M Regeneron merger does [...]
Adagio still hopes to build omicron offense for lead COVID-19 therapy
Adagio still hopes to build omicron offense for lead COVID-19 [...]
BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal
BridgeBio adds another $110M to coffers with voucher sale a [...]
FDA tags Editas’ thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic
FDA tags Editas’ thalassemia cell therapy an orphan drug as [...]
Roche’s TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug
Roche’s TIGIT flop prompts GSK, iTeos to reevaluate next steps [...]
Chutes & Ladders—Moderna CFO Gomez departs after just one day following unearthed investigation
Chutes & Ladders—Moderna CFO Gomez departs after just one day [...]
Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race
Bristol Myers provides Bridge over troubled water with $905M deal [...]
After 20 years, Boehringer vet hits the exit to become CEO at autoimmune biotech SciRhom
After 20 years, Boehringer vet hits the exit to become [...]